Jeffrey M. Trent, Ph.D.

President & Research Director
Translational Genomics Research Institute

Jeffrey M. Trent, Ph.D., F.A.C.M.G., is founding President and Research Director of the Translational Genomics Research Institute (TGen). He specializes in developing and integrating novel “omic” technologies, supporting studies of molecular changes related to the predisposition to, and progression of, human cancers and other complex diseases. He has held numerous faculty appointments including at the University of Arizona, the University of Michigan, Johns Hopkins University and Arizona State University. He is a diplomat of the American College of Medical Genetics, and is a member of the Mayo Clinic Comprehensive Cancer Center. He served on the Board of Directors of the American Association for Cancer Research, and is a member of the American Association for the Advancement of Science, the American Society of Human Genetics and the American Society of Clinical Oncology. Trent is the author of more than 300 manuscripts in the medical literature, has received numerous honors and awards, and has served on the editorial boards of over a dozen medical journals.

Prior to TGen, he served for 10 years as the Scientific Director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health at the National Institutes of Health (NIH) in Bethesda, Maryland. Under his guidance from 1993 to 2002, the division became an internationally recognized research center in the field of human genetics. Following his tenure at the NIH, Trent became the founding president and research director of The Translational Genomics Research Institute in Phoenix, Ariz., a position he holds today.